Inspire Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

Inspire Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$74.52 - $117.06 $316,486 - $497,153	-4,247 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$94.99 - $151.56 $403,422 - $643,675	4,247 New	4,247 $478,000
Q1 2021 Apr 30, 2021	SELL	$99.52 - $215.83 $497 - $1,079	-5 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$80.55 - $106.05 $402 - $530	5 New	5 $0

262

18M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Advisors, LLC with notifications on news.